An oral vaccine based on the Ad5 vector with a double-stranded RNA adjuvant protects mice against respiratory syncytial virus.
Chai P, Shi Y, Yu J, Liu X, Yang M, Li D, Li K, Li S, Kong X, Zhang Q, Sun X, Li J, Li L, Li D, Duan Z.
Chai P, et al. Among authors: li s, li d, li j, li k, li l.
Int Immunopharmacol. 2025 Jan 27;146:113970. doi: 10.1016/j.intimp.2024.113970. Epub 2024 Dec 29.
Int Immunopharmacol. 2025.
PMID: 39736241